MULTIPLE MYELOMA (MM), LYMPHOMA, LARGE B-CELL, DIFFUSE (DLBCL), LYMPHOMA
Clinical trials for MULTIPLE MYELOMA (MM), LYMPHOMA, LARGE B-CELL, DIFFUSE (DLBCL), LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new MULTIPLE MYELOMA (MM), LYMPHOMA, LARGE B-CELL, DIFFUSE (DLBCL), LYMPHOMA trials appear
Sign up with your email to follow new studies for MULTIPLE MYELOMA (MM), LYMPHOMA, LARGE B-CELL, DIFFUSE (DLBCL), LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Pill vs. needle: can Lower-Dose blood thinners protect cancer patients from deadly clots?
Disease control Recruiting nowThis study looks at whether lower doses of two blood-thinning pills (apixaban and rivaroxaban) work as well as standard injections to prevent dangerous blood clots in people with blood cancers like lymphoma, leukemia, and multiple myeloma. About 100 participants will be randomly …
Matched conditions: MULTIPLE MYELOMA (MM), LYMPHOMA, LARGE B-CELL, DIFFUSE (DLBCL), LYMPHOMA
Phase: NA • Sponsor: Medical University of Gdansk • Aim: Disease control
Last updated May 22, 2026 13:55 UTC
-
New cell therapy targets Hard-to-Treat cancers using Biopsy-Guided strategy
Disease control Recruiting nowThis study tests a treatment using donor immune cells (CAR-NK cells) designed to attack cancer. The specific target on the cancer cells is chosen based on a biopsy of the tumor or a blood test. The goal is to see if this approach is safe and can shrink or control advanced solid t…
Matched conditions: MULTIPLE MYELOMA (MM), LYMPHOMA, LARGE B-CELL, DIFFUSE (DLBCL), LYMPHOMA
Phase: PHASE1, PHASE2 • Sponsor: Essen Biotech • Aim: Disease control
Last updated May 13, 2026 15:59 UTC
-
Simple checkup may predict cancer therapy risks in seniors
Knowledge-focused Recruiting nowThis study looks at whether a quick, practical health assessment can predict serious side effects in people aged 65 and older who are about to receive CAR-T cell or bispecific antibody therapy for certain blood cancers. Researchers will track how patients do during and after trea…
Matched conditions: MULTIPLE MYELOMA (MM), LYMPHOMA, LARGE B-CELL, DIFFUSE (DLBCL), LYMPHOMA
Sponsor: University of Zurich • Aim: Knowledge-focused
Last updated May 26, 2026 02:23 UTC
-
AI tutors aim to boost clinical trial enrollment in blood cancer patients
Knowledge-focused Recruiting nowThis study tests whether an AI-powered chatbot can help people with blood cancers (like leukemia or lymphoma) better understand clinical trials and feel more willing to join one. About 196 patients will be randomly assigned to receive either standard information or AI-assisted ed…
Matched conditions: MULTIPLE MYELOMA (MM), LYMPHOMA, LARGE B-CELL, DIFFUSE (DLBCL), LYMPHOMA
Phase: NA • Sponsor: Zhongnan Hospital • Aim: Knowledge-focused
Last updated May 20, 2026 11:54 UTC